Patent · US Active

Homology directed repair compositions for the treatment of hemoglobinopathies

US12110499B2 · kind B2 · utility

0Cited by
4References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 24, 2018
Grant dateOct 8, 2024
Priority date
Expiry dateOct 30, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2800/80
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides improved compositions for the homology directed repair of the human globin locus for the prevention, treatment, or amelioration of at least one symptom of a hemoglobinopathy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.